Bottom line
DLHAX vs IXJ: the short answer
DLHAX (Nomura Healthcare Fund) and IXJ (iShares Global Healthcare ETF) are both mutual funds.
IXJ is cheaper at 0.38% vs 1.21% — a difference of $83 a year per $10,000 invested.
Over five years, IXJ returned +6.4% a year vs +6.2% for DLHAX.
DLHAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
DLHAX vs IXJ side by side
| DLHAX | IXJ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Voya | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.21% | 0.38% |
| Annual cost per $10k | $121 | $38 |
| 10-yr cost on $10k (prospectus) | $2,006 | $480 |
| Max front load | 5.75% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +15.1% | +14.9% |
| 5-yr return (annualized) | +6.2% | +6.4% |
| 10-yr return (annualized) | +9.5% | +8.2% |
| Best quarter | +21.5% | +13.6% |
| Worst quarter | −14.9% | −11.8% |
| Net assets (fund) | $750.2M | $3.8B |
| Number of holdings | 108 | 124 |
| Portfolio turnover | 4% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | DLHAX | IXJ | Difference |
|---|---|---|---|
| 2025 | +22.1% | +14.9% | +7.2% |
| 2024 | +8.5% | +0.6% | +7.9% |
| 2023 | +4.2% | +3.5% | +0.7% |
| 2022 | −1.3% | −4.7% | +3.4% |
| 2021 | −5.3% | +19.5% | −24.8% |
| 2020 | +11.1% | +12.5% | −1.3% |
| 2019 | +31.5% | +23.4% | +8.2% |
| 2018 | −0.8% | +2.9% | −3.7% |
| 2017 | +32.0% | +20.3% | +11.6% |
| 2016 | −4.3% | −6.2% | +1.8% |
Source: Fund prospectus bar charts
Holdings overlap
11 of DLHAX's top 25 holdings also appear in IXJ's top 25.
| Holding | DLHAX | IXJ |
|---|---|---|
| Abbvie Inc | 4.19% | 5.12% |
| Eli Lilly & Company | 4.16% | 10.93% |
| Unitedhealth Group Inc | 3.88% | 4.40% |
| Pfizer Inc | 3.84% | 1.78% |
| Merck & Company Inc | 3.68% | 4.12% |
| Gilead Sciences Inc | 3.54% | 2.04% |
| Astrazeneca Plc | 3.27% | 3.76% |
| Elevance Health Inc | 3.25% | 1.09% |
| Roche Holding Ag | 3.01% | 3.75% |
| Amgen Inc | 2.27% | 2.54% |
| Vertex Pharmaceuticals Inc | 1.66% | 1.64% |
Source: SEC Form N-PORT
DLHAX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between DLHAX and IXJ?
Which is cheaper, DLHAX or IXJ?
Should I own both DLHAX and IXJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.